Tet38 of Staphylococcus aureus Binds to Host Cell Receptor Complex CD36-Toll-Like Receptor 2 and Protects from Teichoic Acid Synthesis Inhibitors Tunicamycin and Congo Red.
Anti-Bacterial Agents
/ pharmacology
Bacterial Proteins
/ genetics
CD36 Antigens
/ genetics
Congo Red
/ pharmacology
Humans
Lipopolysaccharides
/ metabolism
Protein Binding
Staphylococcal Infections
/ genetics
Staphylococcus aureus
/ drug effects
Teichoic Acids
/ biosynthesis
Toll-Like Receptor 2
/ genetics
Tunicamycin
/ pharmacology
CD36
Congo red
S. aureus
TLR-2
Tet38
teichoic acids
tunicamycin
Journal
Infection and immunity
ISSN: 1098-5522
Titre abrégé: Infect Immun
Pays: United States
ID NLM: 0246127
Informations de publication
Date de publication:
07 2019
07 2019
Historique:
received:
05
03
2019
accepted:
14
04
2019
pubmed:
24
4
2019
medline:
5
11
2019
entrez:
24
4
2019
Statut:
epublish
Résumé
Using an affinity column retention assay, we showed that the purified Tet38 membrane transporter of
Identifiants
pubmed: 31010815
pii: IAI.00194-19
doi: 10.1128/IAI.00194-19
pmc: PMC6589061
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Bacterial Proteins
0
CD36 Antigens
0
Lipopolysaccharides
0
TLR2 protein, human
0
Teichoic Acids
0
Toll-Like Receptor 2
0
Tunicamycin
11089-65-9
Congo Red
3U05FHG59S
lipoteichoic acid
56411-57-5
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAID NIH HHS
ID : P01 AI083214
Pays : United States
Organisme : NIAID NIH HHS
ID : R37 AI023988
Pays : United States
Informations de copyright
Copyright © 2019 American Society for Microbiology.
Références
J Bacteriol. 1999 May;181(9):2840-5
pubmed: 10217776
J Bacteriol. 2012 Apr;194(7):1823-34
pubmed: 22287526
J Bacteriol. 2005 Apr;187(7):2395-405
pubmed: 15774883
J Antimicrob Chemother. 2012 Sep;67(9):2143-51
pubmed: 22615298
J Antimicrob Chemother. 2013 Dec;68(12):2766-72
pubmed: 23928023
Eur J Immunol. 2010 Jun;40(6):1639-50
pubmed: 20306471
Infect Immun. 2017 Jan 26;85(2):
pubmed: 27956597
J Bacteriol. 2010 May;192(10):2525-34
pubmed: 20233929
Antimicrob Agents Chemother. 2017 Jul 25;61(8):
pubmed: 28584148
Int Immunol. 2006 Feb;18(2):355-62
pubmed: 16373361
Cell Microbiol. 2010 Dec;12(12):1746-64
pubmed: 20642807
Acta Biochim Biophys Sin (Shanghai). 2010 Dec;42(12):883-92
pubmed: 21051440
J Cell Biol. 2005 Aug 1;170(3):477-85
pubmed: 16061696
J Infect Dis. 2014 May 1;209(9):1485-93
pubmed: 24280365
Antimicrob Agents Chemother. 2018 Jul 27;62(8):
pubmed: 29891612
Clin Microbiol Rev. 2015 Jul;28(3):603-61
pubmed: 26016486
J Immunol. 2008 Nov 15;181(10):7147-56
pubmed: 18981136
Infect Immun. 2000 Nov;68(11):6321-8
pubmed: 11035741
mBio. 2012 Mar 20;3(2):
pubmed: 22434850
J Bacteriol. 2002 Mar;184(5):1370-7
pubmed: 11844766
Infect Immun. 2015 Nov;83(11):4362-72
pubmed: 26324534
J Biol Chem. 1999 Jun 18;274(25):17406-9
pubmed: 10364168
J Leukoc Biol. 2008 Jul;84(1):280-91
pubmed: 18458151
J Biol Chem. 2006 Oct 13;281(41):31002-11
pubmed: 16880211
Cancer Immunol Immunother. 2017 Jun;66(6):799-809
pubmed: 28314957
Front Microbiol. 2018 Jul 02;9:1352
pubmed: 30034372
Exp Dermatol. 2010 Aug;19(8):e296-8
pubmed: 19849713
Cell Microbiol. 2013 Jun;15(6):1026-41
pubmed: 23279065
PLoS Pathog. 2016 May 04;12(5):e1005585
pubmed: 27144276
Nat Chem Biol. 2016 Jan;12(1):40-5
pubmed: 26619249
J Am Chem Soc. 2018 Jan 24;140(3):876-879
pubmed: 29300473